ROYAL BANK OF CANADA - NEURODERM LTD ownership

NEURODERM LTD's ticker is and the CUSIP is M74231107. A total of 5 filers reported holding NEURODERM LTD in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of NEURODERM LTD
ValueSharesWeighting
Q3 2017$39,000
+85.7%
996
+42.3%
0.00%
Q2 2017$21,000
+10.5%
7000.0%0.00%
Q1 2017$19,000
+18.8%
7000.0%0.00%
Q4 2016$16,000
+23.1%
7000.0%0.00%
Q3 2016$13,000
+18.2%
7000.0%0.00%
Q2 2016$11,000
+10.0%
7000.0%0.00%
Q1 2016$10,000
-93.3%
700
-92.0%
0.00%
Q4 2015$149,000
+964.3%
8,736
+1148.0%
0.00%
Q3 2015$14,000
-33.3%
700
-48.8%
0.00%
Q2 2015$21,0001,3680.00%
Other shareholders
NEURODERM LTD shareholders Q4 2017
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 826,799$11,674,0006.53%
Foresite Capital Management III, LLC 292,371$4,128,0003.19%
Avoro Capital Advisors LLC 537,477$7,589,0002.65%
Redmile Group, LLC 1,180,887$16,674,0001.71%
NEXTHERA CAPITAL LP 70,000$988,0001.02%
SCOPIA CAPITAL MANAGEMENT LP 3,383,359$47,773,0000.89%
Foresite Capital Management II, LLC 119,781$1,691,0000.83%
SENZAR ASSET MANAGEMENT, LLC 215,400$3,041,448,0000.60%
SPHERA FUNDS MANAGEMENT LTD. 166,359$2,349,0000.51%
Opaleye Management Inc. 38,500$544,0000.34%
View complete list of NEURODERM LTD shareholders